Instrument-free Cardiac Troponin Assay
Acute Myocardial Infarction (AMI) Detection
Clinical DevelopmentActive; in clinical collaboration with Mayo Clinic
Key Facts
Indication
Acute Myocardial Infarction (AMI) Detection
Phase
Clinical Development
Status
Active; in clinical collaboration with Mayo Clinic
Company
About Chemeleon
Chemeleon's mission is to create simple, accessible, and affordable diagnostic solutions using its proprietary chemical sensor platform. The company's technology enables the detection of a broad range of analytes—including drugs, proteins, and viruses—in a sample-to-answer format visible to the naked eye, requiring no instruments or specialized training. A key strategic achievement is its clinical collaboration with Mayo Clinic to advance its instrument-free cardiac troponin assay for AMI detection. Chemeleon is positioned to transform point-of-care and point-of-need testing by empowering clinicians and consumers with rapid, decentralized diagnostics.
View full company profile